Magnetic approach to prostate cancer enters US trials
This article was originally published in Clinica
Executive Summary
A US trial has begun at the University of California San Francisco of Ablation Technologies' magnetic treatment for prostate cancer. It follows similar studies of the company's technology in Santiago, Chile and Berlin, Germany, which have produced encouraging results.